Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.

Calling him a “tremendous” health advocate, DeMyers adds that leveraging Davis to get the word out about TD will help more people start conversations with their doctors about the condition. Going ...

Mark Read, the former chief executive of WPP, has been appointed chairman of the board at media measurement and analytics business Kantar Media.

Nick Sykes, global chief executive of FutureBrand, McCann Worldgroup’s strategy and design company, has left the business after 15 years.

Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural moments.

A press release issued by the European Commission stated: “The European Commission has approved unconditionally, under the EU Merger Regulation, the proposed acquisition of Interpublic Group of ...

By tapping into unconventional data sources such as wastewater analysis, air quality and weather patterns, we can move from chasing trends to shaping them.

Haymarket Media Group has won B Corp certification across its global business. B Corp status is widely regarded as a benchmark for social and environmental standards, legal transparency and ...

FDA investigates Takeda's blood disorder drug after pediatric death; Australia blocks a $435 million buyout offer for Mayne Pharma from Cosette Pharmaceuticals; Eli Lilly becomes first $1 trillion ...

Ketamine, approved as a 505 (j) generic, carries the same tightly defined indications as its reference product, a Ketalar Injection. These include use as the sole anesthetic agent for diagnostic and ...

Scientists and advocates for trans rights say the change will make it much harder to understand cancer diagnoses and trends among the trans population.

The Trump administration has decided not to pursue the disability cuts that it has been working on all year — and since at least 2019.